CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Publication
, Journal Article
Reed, SD; Anstrom, KJ; Li, Y; Schulman, KA
Published in: Value in Health
May 2007
Duke Scholars
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
May 2007
Volume
10
Issue
3
Start / End Page
A12 / A12
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Reed, S. D., Anstrom, K. J., Li, Y., & Schulman, K. A. (2007). CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA. Value in Health, 10(3), A12–A12. https://doi.org/10.1016/s1098-3015(10)68568-3
Reed, S. D., K. J. Anstrom, Y. Li, and K. A. Schulman. “CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA.” Value in Health 10, no. 3 (May 2007): A12–A12. https://doi.org/10.1016/s1098-3015(10)68568-3.
Reed SD, Anstrom KJ, Li Y, Schulman KA. CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA. Value in Health. 2007 May;10(3):A12–A12.
Reed, S. D., et al. “CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA.” Value in Health, vol. 10, no. 3, Elsevier BV, May 2007, pp. A12–A12. Crossref, doi:10.1016/s1098-3015(10)68568-3.
Reed SD, Anstrom KJ, Li Y, Schulman KA. CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA. Value in Health. Elsevier BV; 2007 May;10(3):A12–A12.
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
May 2007
Volume
10
Issue
3
Start / End Page
A12 / A12
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services